CAS: 1415390-47-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | (R)-BPO-27 REF: AN-AG01EOINCAS: 1415390-47-4 | 98% | To inquire | Mon 15 Jul 24 |
 | (R)-BPO-27 REF: TM-T10591LCAS: 1415390-47-4 | 99.1% | To inquire | Thu 18 Jul 24 |
 | (R)-BPO-27 REF: 3D-QGC39047CAS: 1415390-47-4 | Min. 95% | To inquire | Mon 26 Aug 24 |
Ref: AN-AG01EOIN
| 1mg | 277.00 € | ||
| 2mg | 467.00 € | ||
| 10mg | To inquire |
Estimated delivery in United States, on Monday 15 Jul 2024
(R)-BPO-27
CAS:1415390-47-4
(R)-BPO-27 is an orally active and potent ATP-competitive CFTR inhibitor (IC50: 4 nM) for the …
Formula:
C26H18BrN3O6
Purity:
99.1%
Color and Shape:
Solid
Molecular weight:
548.34
Ref: TM-T10591L
| 2mg | 254.00 € |
Estimated delivery in United States, on Thursday 18 Jul 2024
(R)-BPO-27
CAS:1415390-47-4
(R)-BPO-27 is a membrane permeabilization agent that belongs to the class of enantiomers. It is …
Formula:
C26H18BrN3O6
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
548.34 g/mol
Ref: 3D-QGC39047
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 26 Aug 2024
